Novo Nordisk
NVO
1,196 hedge funds and large institutions have $23.2B invested in Novo Nordisk in 2023 Q2 according to their latest regulatory filings, with 143 funds opening new positions, 443 increasing their positions, 390 reducing their positions, and 84 closing their positions.
70% more first-time investments, than exits
New positions opened: 143 | Existing positions closed: 84
14% more repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 390
4% more funds holding
Funds holding: 1,145 → 1,196 (+51)
9% more call options, than puts
Call options by funds: $486M | Put options by funds: $448M
5% more capital invested
Capital invested by funds: $22.1B → $23.2B (+$1.09B)
0.33% more ownership
Funds ownership: 16.37% → 16.71% (+0.33%)
16% less funds holding in top 10
Funds holding in top 10: 56 → 47 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$190M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$124M |
| 3 |
Tiger Global Management
New York
|
+$104M |
| 4 |
Lazard Asset Management
New York
|
+$85.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$72.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$578M |
| 2 |
Renaissance Technologies
New York
|
-$234M |
| 3 |
Jennison Associates
New York
|
-$106M |
| 4 |
SIG
Senator Investment Group
New York
|
-$67.6M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$42.1M |
NVO Hedge Fund Activity: Q2 2023 in Review
1,196 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2023, worth a combined $23.2B — up 4.9% from $22.1B a quarter earlier.
Buyers outnumbered sellers: 143 funds opened new NVO positions and 84 closed out — a net gain of 59 holders — while 443 added to existing stakes and 390 trimmed.
The largest buyer was 1832 Asset Management, opening a new position worth an estimated $190M. The largest seller was Envestnet Asset Management, cutting an estimated $578M.
- 1,196 institutional investors held Novo Nordisk (NVO) as of Q2 2023, up from 1,145 in Q1 2023.
- Funds reported $23.2B of Novo Nordisk stock for Q2 2023, up 4.9% quarter-over-quarter.
- 143 funds opened new Novo Nordisk positions in Q2 2023 and 84 closed out, a net change of +59 holders.
- The largest Novo Nordisk buyer in Q2 2023 was 1832 Asset Management, an estimated $190M added.
- The largest Novo Nordisk seller in Q2 2023 was Envestnet Asset Management, an estimated $578M sold.
Based on aggregated 13F filings for Q2 2023.